PERRY MICHAEL S

SEC Form 4 insider
ARROWHEAD PHARMACEUTICALS, INC. ($ARWR)
1 thesis · first seen Aug 20, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d111100%-0.4%-0.4%
3d111100%-0.4%-0.4%
1w1100%+1.3%+1.3%
1m111100%-24.0%-24.0%
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ARWRSEC Form 4bearish
Sold 11,600 @ $87.30 avg · $1,012,680 · 2026-08-18

Form 4: PERRY MICHAEL S sold ARWR

PERRY MICHAEL S (Director at ARROWHEAD PHARMACEUTICALS, INC.) reported an open-market sale of 11,600 shares of ARWR at an average $87.30, roughly $1,012,680, in a Form 4 filed 2026-08-20.

At post $87.47Now $86.18-1.5% since postedas of Aug 24, 1:28 PM ET
1d-0.4%
3d-0.4%
1w+1.3%
1m-24.0%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.